Search

Winners of the 2020 European PRRS Research Award

Winners of the 2020 European PRRS Research Award announced Three winner awarded 25,000 euro each for their research.

EMA authorization for Reprocyc ParvoFLEX

Boehringer Ingelheim obtains EMA authorization for Reprocyc® ParvoFLEX, a new porcine parvovirus vaccine

Winners of the 2019 European PRRS Research Award

Winners of the 2019 European PRRS Research Award announced.

Boehringer Ingelheim opens Health Management Centre in China

Boehringer Ingelheim opens Health Management Centre in China The new Health Management Centre integrates animal disease and health diagnostics as well as monitoring tools The centre further strengthens the company’s ability to provide services along the f

Equestrian sports horse health awareness Alex Hua Tian

Together with Olympian trailblazer and eventer Alex Hua Tian, we educate about equine health in China.

Health equity for underserved communities

Introducing initiatives that improve access to healthcare for underserved communities

SIRPα Cancer Immunology Research

Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.

T-cell engagers: Reawakening T-cells to fight cancer

Learn how we are taking cancer on through our approach to immuno-oncology and our T-cell engagers plarform

Groundbeaking of vaccine production center in France

Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health

Winners of BVDzero Scholarship Programme

Boehringer Ingelheim announces winners of BVDzero Scholarship Programme

Boehringer Ingelheim and Fraunhofer partnership

Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products

Henke-Sass Wolf develop needle free device

Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs

New production center for Veterinary Public Health

Boehringer Ingelheim invests more than €200 million to establish a strategic production center for Veterinary Public Health in Lyon, France.

Approval for Aservo EquiHaler equine asthma therapy

Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy

Trailr2-cdh17-antibody-phase1-trial

Boehringer Ingelheim advances a bi-specific therapeutic antibody to first-in-human clinical trial for patients with advanced gastrointestinal cancers

Boehringer Ingelheim acquires Global Stem cell Technology

Boehringer Ingelheim acquires Global Stem cell Technology, Belgian veterinary biotech company, to strengthen its stem cell capabilities in Animal Health

A global production network against supply shortages

The production of medicines is a complex process. We use our global production network to respond to increasing demand.

Big hearts united to help animals in Ukraine

Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe.

FDA approves Jardiance treatment chronic kidney disease

U.S. FDA approves Jardiance® for treatment of adults with chronic kidney disease

The Unwearable Collection™ Evolution

Get ready for the next stage of The Unwearable Collection™

Veterinary oncology - cancer treatment

Our R&D team's efforts toward finding new cancer treatments for pets

Europe needs a vibrant research eco-system

At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.